SOSV: Venture Capital in the Health Diagnostics Sector

, , ,
Integral service around a transaction
BY : Diego GutiérrezJanuary Fri, 2020

SOSV is one of the world's leading Venture Capital in the Health Diagnosticswith a total of 17 investments since 2013.

Its objective is clear: to acquire shareholding in the sector.

This is clear from the Baker Tilly study.

Baker Tilly has produced a study covering 1733 companies from around the world, labelled within the category "...".Diagnostics".

In particular, in the category "Health Diagnostics1043 "The number of roundsand has funds valued at $12.78B.

It is worth noting that, due to the characteristics of the sector, the firms of Venture Capital are common to him.



It is a Swiss company, pioneer in providing specific treatments to patients.

Roche provides automated instruments, software, consumables and informatics solutions for in vitro diagnostics and research.


Biomerieux is a French company, which designs, develops, manufactures and markets in vitro diagnostic systems for clinical and industrial applications..

These include the diagnosis of infectious diseases, cardiovascular diseases and specific cancers.


Quidel is an American company dedicated to the development, manufacturing and commercialisation of diagnostic solutions for POC (Ponit of Care).

In particular, for infectious diseases and women's reproductive health.

In the following, we will analyse SOSVone of the leading investment firms in Venture Capital in the sector Health Diagnostics.


It is a investment firm of Venture Capital which provides multi-stage funding, especially early-stage funding to start-up companies with rounds seed.

It helps develop and scale great ideas from new founders, through financial and intellectual capital.

To date, SOSV has financed more than 900 start-ups.


For SOSV, building a better future means empowering the next generation of entrepreneurs.

Only in this way will they be able to solve the major challenges of today's world.

Notably, almost half of the firm's portfolio is aligned with the United Nations Sustainable Development Goals.

In addition, SOSV is proud to be one of the leading investors in companies founded by women.

SOSV: Venture Capital in the Health Diagnostics SectorSOSV: Venture Capital in the Health Diagnostics SectorSOSV: Venture Capital in the Health Diagnostics Sector


As can be seen from the data shown above, from 2013 to the recently ended 2019, SOSV has made a total of 25 investments, thanks to which has acquired numerous actions by companies in the Health Diagnostics.

2018 was the most productive year, with 8.

As a good firm of Venture CapitalOf those, 25 investments, 17 were in the seedwhile the remaining 8 took place in Late Stage.

The US is the country that has benefited most from them.

The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?